Follow Morning Market Alert Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
The Dow Jones popped this morning on news that a drug from Gilead Sciences Inc. (NASDAQ: GILD) showed some effectiveness in treating patients with the coronavirus.
Shares of the drug company surged 16% after the bell on a report from a Chicago hospital that showed progress from Remdesivir. More on this below.
First, here are the numbers from Thursday for the Dow, S&P 500, and Nasdaq:
| Index | Previous Close | Point Change | Percentage Change |
| Dow Jones | 23,537.68 | +33.33 | +0.14 |
| S&P 500 | 2,799.55 | +16.19 | +0.58 |
| Nasdaq | 8,532.36 | +139.19 | +1.66 |
Now let's take a look at what I consider to be the most important market events to start your day.
The Top Stock Market Stories for Friday
Johns Hopkins University announced that the number of cases around the world has topped 2 million, with more than 650,000 in the United States alone. The number of cases continues to expand across southern states like Louisiana and Georgia. Meanwhile, China's National Health Commission announced that its official death toll had increased by more than 35%.
The Best Stocks to Buy Now: 2020's market free fall has been gut-wrenching, but there's a silver lining: It's opening up a chance to get into great stocks at low prices we might never see again in our lifetime. Click here...
- We've been paying close attention to March economic data from the United States, but today's highlights center on China. This morning, China announced that its economy shrank by 6.8% in the first quarter as the country dealt with the spread of coronavirus. Beijing had engaged in a large shutdown of its economy to reduce human contact and the spread of the virus. This was the first time that the Chinese economy contracted in Q1 since 1992.
- Remdesivir has shown progress in other treatment studies; however, the question is whether it can help reduce investors' anxiety about the surging U.S. unemployment situation. A treatment would likely provide a better path to reopening the U.S. economy sooner than the time it would take to develop a vaccine. The treatment doesn't require universal transmission because it will only require usage among infected people.
Stocks to Watch Today: BA, GE, F, GM, PG
- Shares of Boeing Inc. (NYSE: BA) rallied 7% on news that the aircraft manufacturer plans to reopen production in the Seattle area by April 20. The firm announced it will implement a string of physical distancing standards to prevent the spread of the coronavirus.
- Shares of General Electric Co. (NYSE: GE), Ford Motor Co. (NYSE: F), and General Motors Co. (NYSE: GM) all jumped after they signed contracts with the U.S. government to produce tens of thousands of ventilators. General Electric is working with Ford on a plan to produce 50,000 units. GM will work with Ventec Life Systems to produce 30,000 ventilators.
- Shares of Proctor & Gamble Co. (NYSE: PG) are on the rise this morning after the firm reported strong earnings expectations. The company benefited from the rush of consumers stocking up on staples ahead of the social distancing requirements.
The New Rules for Buying Low and Selling High in Today's Market
If you want to buy low and sell high in today's market, there's only one rule you need to follow.
Today, Tom Gentile is sharing everything - including the exact formula that could magnify your profits faster than you could ever believe.
Follow Money Morning on Facebook and Twitter.
About the Author
Garrett Baldwin is a globally recognized research economist, financial writer, and consultant with degrees from Northwestern, Johns Hopkins, Purdue, and Indiana University. He is a seasoned financial and political risk analyst, with a focus on stocks, hedge funds, private equity, blockchain, and housing policy. He has conducted risk assessment projects for clients in 27 countries, and consulted on policy and financial operations for some of the nation's largest financial institutions, including a $1.5 trillion credit fund, a $43 billion credit and auto loan giant, as well as two of the largest Wall Street banks by assets under management.
Garrett joined Money Map Press as an economist and researcher in 2011, specializing in alternative strategies with an emphasis on fundamental and technical analysis.